IL6 and rheumatoid arthritis: In rheumatoid arthritis, not only the dysregulation of the immune response, especially by the proinflammatory cytokine IL-6, has a serious impact on the progression of the disease, but also the differentiation of osteoclasts and their high expression of gp130, both of which can be reduced by inhibiting gp130 (20, 41).